(Q82224144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Denosumab--a novel strategy to prevent structural joint damage in patients with RA? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Georg Schett

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jean-Pierre David

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

7 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Rheumatology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

634-635

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0927

7 January 2021

Denosumab in postmenopausal women with low bone mineral density

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0927

7 January 2021

Mechanisms of Disease: the link between RANKL and arthritic bone disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0927

7 January 2021

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0927

7 January 2021

Cytokines in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0927

7 January 2021

Expression of osteoclast differentiation factor in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0927

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18839011%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference